Zobrazeno 1 - 10
of 94
pro vyhledávání: '"van der Pal HJ"'
Autor:
Teepen, JC, Kok, JL, Kremer, LC, Tissing, WJ, Van den Heuvel - Eibrink, Marry, Loonen, JJ, Bresters, D, van der Pal, HJ, Versluys, B, van Dulmen-den Broeder, E, Nijsten, Tamar, Hauptmann, M, Hollema, N, Dolsma, WV, van Leeuwen, FE, Ronckers, CM, Caron, HN, Daniels, LA, Bruggink, AH, Grootenhuis, MA, den Hartogh, JG, te Loo, M, Jaspers, MWM, Neggers, S.J.C.M.M., Schaapveld, M
Publikováno v:
Journal of the National Cancer Institute, 111, 8, pp. 845-853
Journal of the National Cancer Institute, 111(8):djy212, 845-853. Oxford University Press
Teepen, J C, Kok, J L, Kremer, L C, Tissing, W J E, van den Heuvel-Eibrink, M M, Loonen, J J, Bresters, D, van der Pal, H J, Versluys, B, van Dulmen-den Broeder, E, Nijsten, T, Hauptmann, M, Hollema, N, Dolsma, W V, van Leeuwen, F E & Ronckers, C C M 2019, ' Long-Term Risk of Skin Cancer among Childhood Cancer Survivors: A DCOG-LATER Cohort Study ', Journal of the National Cancer Institute, vol. 111, no. 8, pp. 845-853 . https://doi.org/10.1093/jnci/djy212
Journal of the National Cancer Institute, 111, 845-853
Journal of the National Cancer Institute, 111(8), 845
Journal of the National Cancer Institute, 111(8), 845-853. Oxford University Press
Journal of the National Cancer Institute, 111(8):212, 845-853. Oxford University Press
Journal of the National Cancer Institute, 111(8):djy212, 845-853. Oxford University Press
Teepen, J C, Kok, J L, Kremer, L C, Tissing, W J E, van den Heuvel-Eibrink, M M, Loonen, J J, Bresters, D, van der Pal, H J, Versluys, B, van Dulmen-den Broeder, E, Nijsten, T, Hauptmann, M, Hollema, N, Dolsma, W V, van Leeuwen, F E & Ronckers, C C M 2019, ' Long-Term Risk of Skin Cancer among Childhood Cancer Survivors: A DCOG-LATER Cohort Study ', Journal of the National Cancer Institute, vol. 111, no. 8, pp. 845-853 . https://doi.org/10.1093/jnci/djy212
Journal of the National Cancer Institute, 111, 845-853
Journal of the National Cancer Institute, 111(8), 845
Journal of the National Cancer Institute, 111(8), 845-853. Oxford University Press
Journal of the National Cancer Institute, 111(8):212, 845-853. Oxford University Press
Background Skin cancer is common after radiotherapy among childhood cancer survivors (CCSs). We studied risks and risk factors for subsequent skin cancers, with emphasis on radiation dose, exposed skin surface area, and chemotherapeutic agents. Metho
Autor:
van Leeuwen Fe, van Dijk M, Dalit Modan-Moses, Dorine Bresters, Claudia Spix, C.B. Lambalk, Jacqueline J. Loonen, Eva Clemens, A. Overbeek, Wassim Chemaitilly, van den Berg Mh, Gertjan L. Kaspers, Beerendonk Ccm, L. L. Robison, Sophie D. Fosså, van der Heiden-van der Loo M, Desiree Grabow, Peter Kaatsch, A.G. Uitterlinden, Melissa M. Hudson, van den Heuvel-Eibrink M, Russell J. Brooke, L. C. M. Kremer, van der Pal Hj, W.J.E. (Wim) Tissing, Falck Winther J, van der Kooi Alf, J. Kruseova, Uta Dirksen, Laven Jse, Claire Berger, Tomáš Kepák, Ronckers Cr, James M. Byrne, Pluijm Smf, Melanie Kaiser, de Vries Ach, Mvan Dulmen-den Broeder E, Linda Broer, Yutaka Yasui, Jesse H. Krijthe, Birgitta Versluys, O. Zolk, Riccardo Haupt
Publikováno v:
Human Reproduction, 36(4), 1120-1133. Oxford University Press
van der Kooi, A L L F, van Dijk, M, Broer, L, van den Berg, M H, Laven, J S E, van Leeuwen, F E, Lambalk, C B, Overbeek, A, Loonen, J J, van der Pal, H J, Tissing, W J, Versluys, B, Bresters, D, Beerendonk, C C M, Ronckers, C R, van der Heiden-van der Loo, M, Kaspers, G L, de Vries, A C H, Robison, L L, Hudson, M M, Chemaitilly, W, Byrne, J, Berger, C, Clemens, E, Dirksen, U, Falck Winther, J, Fosså, S D, Grabow, D, Haupt, R, Kaiser, M, Kepak, T, Kruseova, J, Modan-Moses, D, Pluijm, S M F, Spix, C, Zolk, O, Kaatsch, P, Krijthe, J H, Kremer, L C, Yasui, Y, Brooke, R J, Uitterlinden, A G, van den Heuvel-Eibrink, M M & van Dulmen-den Broeder, E 2021, ' Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function ', Human Reproduction, vol. 36, no. 4, pp. 1120-1133 . https://doi.org/10.1093/humrep/deaa342
Human Reproduction (Oxford, England)
Human Reproduction, 36, 4, pp. 1120-1133
Human Reproduction, 36, 1120-1133
van der Kooi, A-L L F, van Dijk, M, Broer, L, van den Berg, M H, Laven, J S E, van Leeuwen, F E, Lambalk, C B, Overbeek, A, Loonen, J J, van der Pal, H J, Tissing, W J, Versluys, B, Bresters, D, Beerendonk, C C M, Ronckers, C C R, van der Heiden-van der Loo, M, Kaspers, G L, de Vries, A C H, Robison, L L, Hudson, M M, Chemaitilly, W, Byrne, J, Berger, C, Clemens, E, Dirksen, U, Falck Winther, J, Fosså, S D, Grabow, D, Haupt, R, Kaiser, M, Kepak, T, Kruseova, J, Modan-Moses, D, Pluijm, S M F, Spix, C, Zolk, O, Kaatsch, P, Krijthe, J H, Kremer, L C, Yasui, Y, Brooke, R J, Uitterlinden, A G, van den Heuvel-Eibrink, M M & van Dulmen-den Broeder, E 2021, ' Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function ', Human Reproduction, vol. 36, no. 4, pp. 1120-1133 . https://doi.org/10.1093/humrep/deaa342
van der Kooi, A L L F, van Dijk, M, Broer, L, van den Berg, M H, Laven, J S E, van Leeuwen, F E, Lambalk, C B, Overbeek, A, Loonen, J J, van der Pal, H J, Tissing, W J, Versluys, B, Bresters, D, Beerendonk, C C M, Ronckers, C R, van der Heiden-van der Loo, M, Kaspers, G L, de Vries, A C H, Robison, L L, Hudson, M M, Chemaitilly, W, Byrne, J, Berger, C, Clemens, E, Dirksen, U, Falck Winther, J, Fosså, S D, Grabow, D, Haupt, R, Kaiser, M, Kepak, T, Kruseova, J, Modan-Moses, D, Pluijm, S M F, Spix, C, Zolk, O, Kaatsch, P, Krijthe, J H, Kremer, L C, Yasui, Y, Brooke, R J, Uitterlinden, A G, van den Heuvel-Eibrink, M M & van Dulmen-den Broeder, E 2021, ' Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function ', Human Reproduction, vol. 36, no. 4, pp. 1120-1133 . https://doi.org/10.1093/humrep/deaa342
Human Reproduction (Oxford, England)
Human Reproduction, 36, 4, pp. 1120-1133
Human Reproduction, 36, 1120-1133
van der Kooi, A-L L F, van Dijk, M, Broer, L, van den Berg, M H, Laven, J S E, van Leeuwen, F E, Lambalk, C B, Overbeek, A, Loonen, J J, van der Pal, H J, Tissing, W J, Versluys, B, Bresters, D, Beerendonk, C C M, Ronckers, C C R, van der Heiden-van der Loo, M, Kaspers, G L, de Vries, A C H, Robison, L L, Hudson, M M, Chemaitilly, W, Byrne, J, Berger, C, Clemens, E, Dirksen, U, Falck Winther, J, Fosså, S D, Grabow, D, Haupt, R, Kaiser, M, Kepak, T, Kruseova, J, Modan-Moses, D, Pluijm, S M F, Spix, C, Zolk, O, Kaatsch, P, Krijthe, J H, Kremer, L C, Yasui, Y, Brooke, R J, Uitterlinden, A G, van den Heuvel-Eibrink, M M & van Dulmen-den Broeder, E 2021, ' Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function ', Human Reproduction, vol. 36, no. 4, pp. 1120-1133 . https://doi.org/10.1093/humrep/deaa342
STUDY QUESTION Do genetic variations in the DNA damage response pathway modify the adverse effect of alkylating agents on ovarian function in female childhood cancer survivors (CCS)? SUMMARY ANSWER Female CCS carrying a common BR serine/threonine kin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ae7c525b5d2c7161af711da3873f478
https://research.rug.nl/en/publications/063b1e16-52a7-45b0-b625-23f28047a5d1
https://research.rug.nl/en/publications/063b1e16-52a7-45b0-b625-23f28047a5d1
Autor:
van den Berg MH, Overbeek A, Lambalk CB, Kaspers GJL, Bresters D, van den Heuvel-Eibrink MM, Kremer LC, Loonen JJ, van der Pal HJ, Ronckers CM, Tissing WJE, Versluys AB, van der Heiden-van der Loo M, Heijboer AC, Hauptmann M, Twisk JWR, Laven JSE, Beerendonk CCM, van Leeuwen FE, van Dulmen-den Broeder E, LATER-VEVO Study Group DCOG
Publikováno v:
Yearbook of Paediatric Endocrinology.
Autor:
van der Pal HJ, van Dalen EC, van Delden E, van Dijk IW, Kok WE, Geskus RB, Sieswerda E, Oldenburger F, Koning CC, van Leeuwen FE, Caron HN, Kremer LC
Publikováno v:
Journal of Clinical Oncology; 5/1/2012, Vol. 30 Issue 13, p1429-1437, 9p
Autor:
Mulder RL, Thönissen NM, van der Pal HJ, Bresser P, Hanselaar W, Koning CC, Oldenburger F, Heij HA, Caron HN, Kremer LC
Publikováno v:
Thorax; Dec2011, Vol. 66 Issue 12, p1065-1071, 7p
Autor:
van der Pal HJ, van Dalen EC, Hauptmann M, Kok WE, Caron HN, van den Bos C, Oldenburger F, Koning CC, van Leeuwen FE, Kremer LC
Publikováno v:
Archives of Internal Medicine; 7/26/2010, Vol. 170 Issue 14, p1247-1255, 9p
Autor:
Huisman J, Aukema EJ, Deijen JB, van Coeverden SC, Kaspers GJ, van der Pal HJ, Delemarre-van de Waal HA, Huisman, Jaap, Aukema, Eline J, Deijen, Jan Berend, van Coeverden, Silvia Ccm, Kaspers, Gertjan J L, van der Pal, Heleen J H, Delemarre-van de Waal, Henriette A
Publikováno v:
BMC Pediatrics; 2008, Vol. 8, p25-25, 1p
Autor:
van der Perk MEM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. Electronic address: m.e.m.vanderperk@prinsesmaximacentrum.nl., Broer L; Department of Internal Medicine, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands., Yasui Y; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee., Laven JSE; Department of Obstetrics and Gynecology, Erasmus MC University Medical Center, Rotterdam, the Netherlands., Robison LL; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee., Tissing WJE; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of pediatric oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Versluys B; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Bresters D; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Kaspers GJL; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Lambalk CB; Department of Obstetrics and Gynaecology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Overbeek A; Department of Obstetrics and Gynaecology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Loonen JJ; Department of Haematology, Radboud University Medical Center, Nijmegen, the Netherlands., Beerendonk CCM; Department of Obstetrics and Gynaecology, Radboud University Medical Center, Nijmegen, the Netherlands., Byrne J; Boyne Research Institute, Bettystown, Ireland., Berger C; Department of Paediatric Oncology, University Hospital, Saint-Etienne, France; Lyon University, Jean Monnet University, INSERM, Sainbiose, Saint-Etienne, France., Clemens E; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van Dulmen-den Broeder E; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Dirksen U; Pediatrics III, West German Cancer Centre, University Hospital Essen, Essen, Germany; German Cancer Research Centre, DKTK, Sites Duesseldorf-Essen, Essen, Germany., van der Pal HJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., de Vries ACH; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Winther JF; Danish Cancer Society Research Center, Childhood Cancer Research Group, Copenhagen, Denmark; Department of Clinical Medicine, Faculty of Health, Aarhus University and University Hospital, Aarhus, Denmark., Ranft A; Pediatrics III, West German Cancer Centre, University Hospital Essen, Essen, Germany; German Cancer Research Centre, DKTK, Sites Duesseldorf-Essen, Essen, Germany., Fosså SD; Department of Oncology, Oslo University Hospital, Oslo, Norway., Grabow D; Division of Childhood Cancer Epidemiology, German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Muraca M; Division of Pediatric Hematology and Oncology, DOPO Clinic, IRCCS Istituto Giannina Gaslini, Via G. Gaslini, Genoa, Italy., Kaiser M; Division of Childhood Cancer Epidemiology, German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Kepák T; University Hospital Brno, International Clinical Research Center (FNUSA-ICRC), Masaryk University, Brno, Czech Republic., Kruseova J; Department of Pediatric Hematology and Oncology, Motol University Hospital, Prague, Czech Republic., Modan-Moses D; The Edmond and Lily Safra Children's Hospital, Chaim Sheba Medical Center, Tel Hashomer, Israel; The Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel., Spix C; Division of Childhood Cancer Epidemiology, German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Zolk O; Institute of Clinical Pharmacology, Brandenburg Medical School Theodor Fontane, Immanuel Klinik Rüdersdorf, Neuruppin, Germany., Kaatsch P; Division of Childhood Cancer Epidemiology, German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Kremer LCM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Brooke RJ; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee., Wang F; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee., Baedke JL; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee., Uitterlinden AG; Department of Internal Medicine, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands., Bos AME; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Reproductive Medicine, University Medical Center, Utrecht, the Netherlands., van Leeuwen FE; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Ness KK; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee., Hudson MM; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee; Division of Survivorship, Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee., van der Kooi ALF; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Obstetrics and Gynecology, Erasmus MC University Medical Center, Rotterdam, the Netherlands., van den Heuvel-Eibrink MM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Division of Child Health, Wilhelmina Children's Hospital, University Medical Center Utrecht, the Netherlands.
Publikováno v:
Fertility and sterility [Fertil Steril] 2024 Sep; Vol. 122 (3), pp. 514-524. Date of Electronic Publication: 2024 May 09.
Autor:
Bates JE; Department of Radiation Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia. Electronic address: james.edward.bates@emory.edu., Rancati T; Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Keshavarz H; University Health Network, Toronto, Ontario, Canada., Gagliardi G; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Aznar MC; Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom., Howell RM; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, Texas; Graduate School of Biomedical Sciences, MD Anderson UT Health, Houston, Texas., Shrestha S; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, Texas; Graduate School of Biomedical Sciences, MD Anderson UT Health, Houston, Texas., Moiseenko V; Department of Radiation Medicine and Applied Sciences, University of California, San Diego, La Jolla, California., Yorke E; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York., Armenian S; Department of Pediatrics, City of Hope, Duarte, California., Kremer L; Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands., Chen MH; Departments of Cardiology and Pediatrics, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., van der Pal HJ; Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands., Cutter DJ; Clinical Trial Service Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom., Constine LS; Departments of Radiation Oncology and Pediatrics, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York., Hodgson D; Department of Radiation Oncology, Princess Margaret Hospital, Toronto, Ontario, Canada.
Publikováno v:
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2024 Jun 01; Vol. 119 (2), pp. 522-532. Date of Electronic Publication: 2023 Apr 14.
Autor:
Roganovic J; Department of Pediatric Hematology and Oncology, Children's Hospital Zagreb, Zagreb, Croatia; Faculty of Biotechnology and Drug Development, University of Rijeka, Rijeka, Croatia., Haupt R; Epidemiology and Biostatistics Unit and DOPO Clinic, IRCCS Istituto Giannina Gaslini, Genova, Italy., Bárdi E; St. Anna Childrens Hospital, Wien; Department of Pediatrics and Adolescent Medicine, Johannes Kepler University Linz, Kepler University Hospital, Linz, Austria., Hjorth L; Department of Pediatrics, Skane University Hospital; Department of Clinical Sciences, Lund University, Lund, Sweden., Michel G; Faculty of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland., Pavasovic V; Department of Paediatric Haematology and Oncology, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom., Scheinemann K; Faculty of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland; Division of Hematology-Oncology, Children's Hospital of Eastern Switzerland, St Gallen, Switzerland; Department of Pediatrics, McMaster Children's Hospital and McMaster University, Hamilton, Canada., van der Pal HJ; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Zadravec Zaletel L; Radiotherapy Department, Institute of Oncology Ljubljana, Ljubljana; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia,., Amariutei AE; Youth Cancer Europe, Cluj-Napoca, Romania., Skinner R; Department of Paediatric and Adolescent Haematology and Oncology, Great North Children's Hospital, Royal Victoria Infirmary; Translational and Clinical Research Institute, and Centre for Cancer, Newcastle University, Newcastle upon Tyne, United Kingdom.roderickskinner@nhs.net.
Publikováno v:
Acta medica academica [Acta Med Acad] 2024 Apr; Vol. 53 (1), pp. 59-80.